[1] Leung J, Broder KR, Marin M. Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review. Expert Rev Vaccin, 2017; 16, 391−400. doi:  10.1080/14760584.2017.1294069
[2] Meng QH, Cheng XP, Liu DD, et al. One single-center cross-sectional investigation on varicella antibody level of all age groups in Chinese people. Hum Vaccin Immunother, 2021; 17, 358−62. doi:  10.1080/21645515.2020.1784653
[3] Wang MM, Li XD, You MY, et al. Epidemiological characteristics of varicella outbreaks - China, 2006-2022. China CDC Wkly, 2023; 5, 1161−6. doi:  10.46234/ccdcw2023.218
[4] Sui HT, Guo Y, Wang B, et al. Global varicella vaccination strategy in children and research progress. Chin J Viral Dis, 2023; 13, 294−8. (In Chinese)
[5] Qi XQ, Zhu HS, Chen W, et al. Epidemiological characteristics and trend prediction of varicella in Fujian Province from 2014 to 2018. Chin J Dis Control Prev, 2021; 25, 43−7,112. (In Chinese)
[6] Xuan K, Zhang N, Li T, et al. Epidemiological characteristics of varicella in Anhui Province, China, 2012-2021: surveillance study. JMIR Public Health Surveill, 2024; 10, e50673. doi:  10.2196/50673
[7] Hirae K, Hoshina T, Koga H. Impact of the COVID-19 pandemic on the epidemiology of other communicable diseases in Japan. Int J Infect Dis, 2023; 128, 265−71. doi:  10.1016/j.ijid.2023.01.013
[8] Zhu H, Zhao H, Ou R, et al. Spatiotemporal epidemiology of varicella in Chongqing, China, 2014-2018. Int J Environ Res Public Health, 2020; 17, 662. doi:  10.3390/ijerph17020662
[9] Shapiro ED, Marin M. The effectiveness of varicella vaccine: 25 years of postlicensure experience in the United States. J Infect Dis, 2022; 226, S425−30. doi:  10.1093/infdis/jiac299
[10] Wang M, Zeng X, Zhang YP, et al. Epidemiological characteristics of varicella public health emergency events in China, 2007-2021. Chin J Vaccin Immun, 2023; 29, 274−9. (In Chinese)